Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

Study casts light on DNA damage in esophageal cancer

Oct. 27, 2021

New mouse model shows possibility of reversing autosomal dominant polycystic kidney disease

Oct. 27, 2021

Diverse Biotech's DBT-12733 shows efficacy against glioblastoma tumor cells

Oct. 27, 2021

CRISP/Cas9 modulation of utrophin as a strategy to treat DMD

Oct. 27, 2021

Vyne reports findings with BET inhibitor VYN-201 in animal model and ex vivo human tissue study

Oct. 27, 2021

188Re-Rituximab shows promise for treating CD20-overexpressing cancers

Oct. 27, 2021

Ec1-LoPE DARPin-toxin fusion protein evaluated with trastuzumab for ovarian cancer

Oct. 27, 2021

New TYK2 inhibitors synthesized at Eternity Bioscience

Oct. 27, 2021

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

Oct. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...